|
|
Media |
| |
| 2008 | 2007 | 2006 |
| |
| December 31,
2008 |
|
Guest
Editorial by Robert D. Gibbons published in Psychiatric Annals |
 |
|
In the December
2008 issue of Psychiatric Annals, guest editor
Robert D. Gibbons provides a review of the important statistical
methodologies and issues that have arisen in the analysis
of longitudinal data over the past 15 years.
The guest editorial, Design
and Analysis of Longitudinal Studies ,
introduces several articles that focus on important
topics such as sample size determination for clustered and/or
longitudinal studies, the role of the intent-to-treat principle
in longitudinal studies and various alternatives,
missing data in longitudinal clinical trials and balancing
treatment and comparison groups in longitudinal studies.
Read this issue's articles |
| |
|
|
| |
| April 2, 2008 |
|
Computerized
adaptive testing shown to dramatically reduce administration
time and patient and clinician burden |
 |
|
In the lead article of the April
2008 issue of Psychiatric Services, Robert D.
Gibbons et al. investigate the combination of item response
theory and computerized adaptive testing (CAT) as a means
to reduce the time required to administer a collection of
extensive, fixed-length psychiatric instruments for mental
health measurement and diagnostic purposes.
The methodology
described in Using
Computerized Adaptive Testing to Reduce the Burden of Mental
Health Assessment streamlines
and individualizes the measurement process, increases measurement
precision and decreases respondent and clinician burden.
The
article is featured in the issue's This
Month's Highlights and
is further discussed in the Commentary, Are
We Ready for Computerized Adaptive Testing? |
| |
|
|
| |
|
|
| March 31, 2008 |
|
Robert D. Gibbons interviewed
on ABC7 News |
In a recent appearance on the
ABC7 News Special Segment, Too
young to die, Dr. Gibbons spoke on the relation between
the 2004 introduction by the FDA of the "black box" warning
on anti-depressants and the recent decrease in SSRI prescriptions
and increase in youth suicide rates.
|
| |
|
|
| |
|
|
| September 6, 2007 |
|
Robert D. Gibbons
et al. study in the news |
The latest study by Robert
D. Gibbons et al. on the effects of the FDA's "black box" warnings
on SSRI prescriptions and youth suicide rates is discussed
in several recent articles, some of which are listed below:
Youth
Suicides Increased As Antidepressant Use Fell 
by The Washington Post
Suicide
Rises in Youth; Antidepressant Debate Looms 
by The New York Times
As
youth suicides increase, FDA's label rule criticized 
by Chicago Tribune |
| |
|
|
| |
|
|
| September 1,
2007 |
|
Study connects suicidality warnings to a decrease in
SSRI prescriptions and an increase in youth suicide rates |
 |
|
The study examines whether
U.S. and European regulatory agencies issued suicidality warnings
led to a decrease in SSRI prescriptions for children and adolescents
and consequently an increase in suicide rates as a result of
untreated depression.
These findings are presented in the “Early
Evidence on the Effects of Regulators’ Suicidality Warnings on SSRI Prescriptions
and Suicide in Children and Adolescents” article by Robert D. Gibbons,
Ph.D., C. Hendricks Brown, Ph.D., Kwan Hur, Ph.D., Sue M. Marcus, Ph.D.,
Dulal K. Bhaumik, Ph.D., Joëlle A. Erkens, Pharm.D., Ph.D., Ron M.C.
Herings, Pharm.D., Ph.D., and J. John Mann, M.D.
The article appears in the September
2007 issue of The American Journal of Psychiatry. |
| |
|
|
| |
|
|
| July 16, 2007 |
|
Robert D. Gibbons quoted
in Newsweek article |
Robert D. Gibbons, Ph.D., is
quoted in a Newsweek
article with
respect to the "black box" warning introduced by
the Food and Drug Administration in 2004 to alert patients
and physicians
that
antidepressants
could lead to an "increased risk of suicidal thinking and behavior among
children and adolescents."
This article comes at a time when several new
studies conclude that it is much more likely that suicidal behavior leads
to treatment than that treatment leads to suicidal behavior.
In light of the findings
of these studies many experts are calling on the FDA to modify and even repeal
its warning. |
| |
|
|
| |
|
|
| July 10, 2007 |
|
Robert D. Gibbons quoted
in New York Times article |
Robert D. Gibbons, director
of the Center for Health Statistics and professor of biostatistics
and psychiatry, is quoted in a New
York Times article about
his recent study that found antidepressants lower the risk
of suicide attempt
in adults with depression —a finding that questions the FDA's recent decision
to add a "black box" warning on antidepressant
drugs for young adults.
|
| |
|
|
| |
|
|
July 1, 2007
|
|
Study
of suicide in depressed veterans published
in The American Journal of Psychiatry
|
 |
|
A study of the relationship
between antidepressant treatment and suicide attempts in adult
patients in the Veterans Administration health care system
found that suicide attempt rates were lower among patients
who were treated with antidepressants than among those who
were not.
These findings are presented in the “Relationship
Between Antidepressants and Suicide Attempts: An Analysis of the Veterans
Health Administration Data Sets” article by Robert
D. Gibbons, Ph.D., C. Hendricks Brown, Ph.D., Kwan Hur,
Ph.D., Sue M. Marcus, Ph.D., Dulal K.
Bhaumik, Ph.D.,
and J. John Mann, M.D.
The article appears in the July
2007 issue of The American Journal of Psychiatry, the official
journal of the American Psychiatric Association. |
| |
|
|
| |
|
|
| November
1, 2006 |
|
Study of early adolescent
suicide published in The
American Journal of Psychiatry |
 |
|
A county-by-county study of
the entire United States found that suicide rates among children
ages 5-14 during the period 1996-1998 were lower in counties
with higher numbers of antidepressant pills prescribed per
person.
These findings are presented in the article "The
Relationship Between Antidepressant Prescription Rates
and Rate of Early Adolescent Suicide" by
Robert D. Gibbons, Ph.D., Kwan Hur, Ph.D., Dulal K. Bhaumik,
Ph.D., and J. John Mann, M.D., of the Center for Health
Statistics, University of Illinois at Chicago, and the
New York State Psychiatric
Institute and Columbia University College of Physicians
and Surgeons.
The article is also highlighted in the editorial "How
Can We Know Whether Antidepressants Increase Suicide Risk?" by
Dr. Gregory E. Simon, M.D., M.P.H., of the Group Health's Center for Health
Studies and in
a News Release by
the American Psychiatric
Association. |
| |
|
|
| |
|
|
| September 23,
2006 |
|
Report on national drug
safety discussed in New York Times article |
The New York Times article Study
Condemns F.D.A.’s Handling of Drug Safety discusses
the findings and recommendations of the report, and its role
in intensifying the debate over the safety of the nation's
drug supply and the adequacy of the government's oversight.
|
| |
|
|
| |
|
|
| September 22,
2006 |
|
Institute of Medicine committee
reviews the U.S. Drug Safety System |
 |
|
A 15-member Institute of Medicine
committee, which includes Robert D. Gibbons, Ph.D., has issued
a report, The
Future of Drug Safety: Promoting and Protecting the Health
of the Public, that reviews the drug safety policies
of the U.S. Food and Drug Administration (FDA) and offers a
broad set of recommendations to ensure that consideration of
safety extends from before product approval through the entire
time the product is marketed and used.
|
| |
|
|
| |
|
|
| August 30,
2006 |
|
Robert D. Gibbons
et al. article to be published in The American Journal
of Psychiatry |
"The Relationship Between
Antidepressant Prescription Rates and Rate of Early Adolescent
Suicide" by Robert D. Gibbons, Ph.D., Kwan Hur, Ph.D.,
Dulal K. Bhaumik, Ph.D., and J. John Mann, M.D., will be
highlighted in The
American Journal of Psychiatry's In
This Issue section
and featured in a newsletter.
|
| |
|
|
| |
|
|
| May 29, 2006 |
|
Robert D. Gibbons, Ph.D.,
serves on NIH expert panel on U.S. use of multivitamins |
Robert D. Gibbons, Ph.D.,
was one of the 13 members of the expert panel convened by
the National
Institutes of Health to assess the effectiveness and safety
of multivitamin and mineral supplements in chronic disease
prevention.
The panel's findings received wide media coverage
all around the world. Read more about the evidence taken
into consideration
and the panel's conclusions
in the "Benefits
of Multivitamins Unclear, Panel Finds" article ,
featured on page
70 of Clinical Psychiatry News, Volume 34, Issue 7. |
| |
|
|
|
|